Application

UABT

Biohaven Therapeutics Ltd.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90511057
Filing Date: 02/04/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90511057
MARK INFORMATION
*MARK UABT
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT UABT
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Biohaven Therapeutics Ltd.
*MAILING ADDRESS 215 Church Street
*CITY New Haven
*STATE
(Required for U.S. applicants)
Connecticut
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
06510
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited company (ltd.)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED British Virgin Islands
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 001 
*IDENTIFICATION Binding compounds for laboratory and research use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 005 
*IDENTIFICATION Biomedical binding compounds for pharmaceutical or medical use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Research and development in the field of binding compounds for pharmaceutical and medical purposes.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Monica Riva Talley
ATTORNEY DOCKET NUMBER 4501.0700000
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Sterne, Kessler, Goldstein & Fox P.L.L.C.
STREET 1100 New York Avenue, N.W.
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20005
PHONE 202-371-2600
FAX 202-371-2540
EMAIL ADDRESS tm@sternekessler.com
OTHER APPOINTED ATTORNEY Tracy-Gene G. Durkin, Dana N. Justus, Shana L. Olson, Ivy Clarice Estoesta and Lauriel F. Dalier
CORRESPONDENCE INFORMATION
NAME Monica Riva Talley
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tm@sternekessler.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) mtalley@sternekessler.com; djustus@sternekessler.com; jseeleyhall@sternekessler.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE /Monica Riva Talley/
SIGNATORY'S NAME Monica Riva Talley
SIGNATORY'S POSITION Attorney of Record, Member of Virginia and Washington, DC Bars
SIGNATORY'S PHONE NUMBER 202-371-2600
DATE SIGNED 02/04/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90511057
Filing Date: 02/04/2021

To the Commissioner for Trademarks:

MARK: UABT (Standard Characters, see mark)
The literal element of the mark consists of UABT. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Biohaven Therapeutics Ltd., a limited company (ltd.) legally organized under the laws of British Virgin Islands, having an address of
      215 Church Street
      New Haven, Connecticut 06510
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 001:  Binding compounds for laboratory and research use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 005:  Biomedical binding compounds for pharmaceutical or medical use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Research and development in the field of binding compounds for pharmaceutical and medical purposes.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Monica Riva Talley. Other appointed attorneys are Tracy-Gene G. Durkin, Dana N. Justus, Shana L. Olson, Ivy Clarice Estoesta and Lauriel F. Dalier. Monica Riva Talley of Sterne, Kessler, Goldstein & Fox P.L.L.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1100 New York Avenue, N.W.
      Washington, District of Columbia 20005
      United States
      202-371-2600(phone)
      202-371-2540(fax)
      tm@sternekessler.com
The docket/reference number is 4501.0700000.
Monica Riva Talley submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Monica Riva Talley
       PRIMARY EMAIL FOR CORRESPONDENCE: tm@sternekessler.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mtalley@sternekessler.com; djustus@sternekessler.com; jseeleyhall@sternekessler.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Monica Riva Talley/   Date: 02/04/2021
Signatory's Name: Monica Riva Talley
Signatory's Position: Attorney of Record, Member of Virginia and Washington, DC Bars
Signatory's Phone Number: 202-371-2600
Signature method: Sent to third party for signature
Payment Sale Number: 90511057
Payment Accounting Date: 02/04/2021

Serial Number: 90511057
Internet Transmission Date: Thu Feb 04 17:11:04 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20210204171104
764703-90511057-76075a6493d77dfe90fad4ce
905664944163c97afca75b863efc2e4a5961e052
-CC-11032995-20210203152308758323

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed